June 28, 2025
Children with Post COVID-19 Multisystem Inflammatory Syndrome Display Unique Pathophysiological Metabolic Phenotypes | Stellate Ganglion Block for the Treatment of COVID-19-Induced Parosmia: A Randomized Clinical Trial
Children with Post COVID-19 Multisystem Inflammatory Syndrome Display Unique Pathophysiological Metabolic Phenotypes | Stellate Ganglion Block for the Treatment of COVID-19-Induced Parosmia: A Randomized Clinical Trial
Pediatric Antibiotic Use Associated with Respiratory Syncytial Virus and Influenza in the United States, 2008-2018 | Effectiveness and Impact of Nirsevimab in Chile During the First Season of a National Immunization Strategy against RSV (NIRSE-CL): A Retrospective Observational Study
Oseltamivir Treatment vs Supportive Care for Seasonal Influenza Requiring Hospitalization In Adults with Influenza Requiring Admission to Hospital | Long-term Outcomes of Patients with Pre-existing Coronary Artery Disease after SARS-CoV-2 Infection
FDA approves new mRNA COVID vaccine MNEXSPIKE from Moderna | Safety and Efficacy of Pemivibart, a Long-Acting Monoclonal Antibody, for Prevention of Symptomatic COVID-19: Interim Results From a Phase 3 Randomized Clinical Trial (CANOPY) | Genome-wide Association Study of Long COVID
Cardiac Events in Adults Hospitalized for Respiratory Syncytial Virus vs COVID-19 or Influenza | Protection Against Breakthrough Infection After Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in Avon Longitudinal Study of Parents and Children (ALSPAC) Participants | Clinical Effectiveness of Oral Antiviral Treatment for Non-hospitalized High-risk Patients with COVID-19 During Omicron JN.1 Subvariant Wave: A U.S.-based Propensity-matched Cohort Study
Air and Surface Sampling for Clade Ib Monkeypox Virus in United Kingdom Hospitals, 2024 to 2025 | The Clinical Impact of Prolonged Steroid Therapy in Severe COVID-19 Patients: A Retrospective Cohort Study with Propensity Score Matching | Antibiotic Treatment in Patients Hospitalized for Nonsevere COVID-19 | Self-reported Health, Neuropsychological Tests and Biomarkers in Fully Recovered COVID-19 Patients vs Patients with Post-COVID Cognitive Symptoms: A Pilot Study
A Phase 3 Safety and Efficacy Study of Baloxavir Marboxil in Children Less Than 1 Year Old With Suspected or Confirmed Influenza | COVID-19 Infection History as a Risk Factor for Early Pregnancy Loss: Results from the Electronic Health Record-based Southeast Texas COVID and Pregnancy Cohort Study | Immunogenicity and Safety of Influenza and COVID-19 Multicomponent Vaccine in Adults ≥50 Years: A Randomized Clinical Trial
Live Zoster Vaccination and Cardiovascular Outcomes: A Nationwide, South Korean Study | Impact of Nirsevimab on RSV and Non-RSV Severe Respiratory Infections in Hospitalized Infants | Early Effectiveness of the BNT162b2 KP.2 Vaccine against COVID-19 in the U.S. Veterans Affairs Healthcare System
Tocilizumab and IVIG Experience During the Service Follow-up in Patients with Severe COVID-19 Pneumonia | Risk of New-Onset Type 2 Diabetes among Vaccinated Adults after Omicron or Delta Variant SARS-CoV-2 Infection
Efficacy, Safety, and Immunogenicity of the AS01E-adjuvanted Respiratory Syncytial Virus Prefusion F Protein Vaccine (RSVPreF3 OA) in Older Adults Over Three Respiratory Syncytial Virus Seasons (AReSVi-006): A Multicentre, Randomized, Observer-blinded, Placebo-Controlled, Phase 3 Trial | Long-Term Stroke and Mortality Risk Reduction Associated With Acute-Phase Paxlovid Use in Mild-to-Moderate COVID-19
A comprehensive educational resource on all aspects of parasitic diseases and their impact on humanity around the globe.
Help bring the latest medical and basic biological information pertaining to diseases caused by eukaryotic parasites to every practicing physician and medical student within the United States.